Comments

Response to Comment on: “Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel”

Department of Hematopathology, MD Anderson Cancer Center, Houston
Hematopathology Section, Department of Pathology, Hospital Clínic, Barcelona
Department of Biomedicine and Prevention, University Tor Vergata, Rome
Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel
MLL Munich Leukemia Laboratory, Munich
Department of Pathology, Baptist Health South Florida, Miami, Florida
Department of Hematology Laboratory and FlowCytometry, Lyon University Hospital, CHU-HCL, Lyon Sud, Pierre Benite
Auckland City Hospital, Auckland, New Zealand
Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel
Dept Pathology, Peter MacCallum Cancer Centre, Melbourne
Department of Pathology and Laboratory Medicine, Children’s Hospital of Los Angeles, CA
School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham
Haematologica Early view Apr 16, 2026 https://doi.org/10.3324/haematol.2026.300980